Watch this company for free updates
Simply enter your email address below and we will send you an email when the company files any documents or there is a change to their credit report.
We require your email address in order to send you alerts by email. You can unsubscribe at any time.
Thank you, you are now watching this company.
You will receive email updates when this company's information changes.
You can choose which alerts you receive and can unsubscribe at any time.
Unlock NEXTPHARMA TECHNOLOGIES HOLDING LIMITED's Credit Report?
Unlock The Full Report
- Credit score, financials and risk data
- Directors, shareholders and ownership
- CCJs, payment behaviour and filing history
- 5 official Companies House documents
- Instant download and online viewing
- Email alerts for key changes
- Personal monitoring dashboard
Upgrade to Lite
- 5 credit reports
- 100 accounts downloads
- 100 accounts exports
Your plan will start immediately and the time remaining on your existing plan will be refunded
Yes, upgrade to LiteNEXTPHARMA TECHNOLOGIES HOLDING LIMITED
83 VICTORIA STREET, LONDON, SW1H 0HW
Buy Report - £20
Download PDF
Unlock the Full Company Report
- ✓ Check whether this company is legitimate
- ✓ See if this company is likely to run into financial trouble
- ✓ Find out who owns and runs the company
- ✓ Avoid risky business relationships
- ✓ Get instant updates if anything important changes
- ✓ Access official company documents for free
NEXTPHARMA TECHNOLOGIES HOLDING LIMITED
Private limited with Share Capital
Active - Accounts Filed
02 January 2003
21100 Manufacture of basic pharmaceutical products - Manufacture of basic pharmaceutical products
Available to 30 Sep 2025. Next accounts due by 30 Sep 2026
Is NEXTPHARMA TECHNOLOGIES HOLDING LIMITED in debt to you?
Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.
Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.
We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.
Current Directors & Secretaries
For a full in-depth analysis on each of these directors, click any of the links below
| Name | Role | Date Of Birth | Appointed |
|---|---|---|---|
| Mr Ajeeth Kumar Enjeti | Director | ||
| Mr Alan Jonathan Dodsworth | Company Secretary |
Previous Directors & Secretaries
Mortgages and Charges
Total Outstanding
1
Total Satisfied
7
| Type | Created | Registered | Persons Entitled | Status |
|---|---|---|---|---|
| Glas Sas As Security Agent | OUTSTANDING | |||
| Deutsche Bank Luxembourg S.a. As Security Agent (Acting On Its Own Account) | SATISFIED | |||
| Deutsche Bank Luxembourg S.a. (As Trustee For Each Of The Secured Parties) (The ?security" Agen | SATISFIED | |||
| Fixed And Floating Security Document | Isaac Management S.a R.l. & Partners S.c.a. | SATISFIED | ||
| Account Charge | National Westminster Bank PLC | SATISFIED | ||
| Deed Of Assignment | National Westminster Bank PLC | SATISFIED | ||
| Debenture | National Westminster Bank PLC | SATISFIED | ||
| Rent Deposit Deed | Catcode Limited | SATISFIED |
Key Financials
| Accounts | |||||
|---|---|---|---|---|---|
| Cash | £140,796.00 | £86,042.00 | £75,783.00 | £99,130.00 | £370,593.00 |
| Net Worth | -£48,404,311.00 | -£9,513,297.00 | -£4,692,657.00 | -£2,061,739.00 | -£184,007.00 |
| Total Current Liabilities | £222,492.00 | £246,827.00 | £360,390.00 | £281,739.00 | £421,324.00 |
| Total Current Assets | £405,875.00 | £401,529.00 | £407,544.00 | £235,652.00 | £486,672.00 |
Frequently Asked Questions about NEXTPHARMA TECHNOLOGIES HOLDING LIMITED
Detailed answers about NEXTPHARMA TECHNOLOGIES HOLDING LIMITED, including incorporation, status, business activity, and accounts information.
When was NEXTPHARMA TECHNOLOGIES HOLDING LIMITED founded?
NEXTPHARMA TECHNOLOGIES HOLDING LIMITED was officially incorporated on 02 January 2003 and is registered under company number 04627290. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEXTPHARMA TECHNOLOGIES HOLDING LIMITED?
Private limited with Share Capital. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEXTPHARMA TECHNOLOGIES HOLDING LIMITED?
NEXTPHARMA TECHNOLOGIES HOLDING LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEXTPHARMA TECHNOLOGIES HOLDING LIMITED do?
NEXTPHARMA TECHNOLOGIES HOLDING LIMITED operates in the following sector: 21100 Manufacture of basic pharmaceutical products - Manufacture of basic pharmaceutical products . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.
What is NEXTPHARMA TECHNOLOGIES HOLDING LIMITED's registered address?
The registered office address of NEXTPHARMA TECHNOLOGIES HOLDING LIMITED is 83, Victoria Street, London, Westminster, SW1H 0HW. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEXTPHARMA TECHNOLOGIES HOLDING LIMITED financially stable?
Based on the latest accounts up to 30 Sep 2025, NEXTPHARMA TECHNOLOGIES HOLDING LIMITED has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Sep 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.